CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
NCT Number: NCT01590511
The main objective of this study is to show that the variation of the subaortic velocity time integral after a mini test by filling 100 cc of normal saline over 1 minute (ΔITV100) is predictive of response to filling (defined as an increase in aortic velocity time integral measured by transthoracic ultrasound over 15% after administration of 500 cc of normal saline over 15 minutes) in non-ventilated shock patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nîmes, 30029, France
The secondary objectives of this study include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline; 26 minutes
Time frame: baseline; 15 minutes
Time frame: baseline; 26 minutes
(bpm,%)
Time frame: baseline; 26 minutes
Time frame: baseline; 26 minutes
Time frame: baseline; 26 minutes
Time frame: baseline; 26 minutes
Time frame: baseline; 8 minutes
(DiameterMax-DiameterMin) / DiameterMax (cm;%)
Centre Hospitalier Universitaire de Nīmes
Other
Acronym: IVT NonVent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07061457
Blood Pressure, Circulatory Failure
Krakow, Poland
View Trial DetailsNCT07206732
Circulatory Failure, Disease Attributes
Asyut, Sahel Selim, Egypt
View Trial DetailsNCT07020637
Critical Illness, Disease Attributes
Las Vegas, Nevada, United States
View Trial DetailsNCT02728791
Cardiac Output, Low, Cardiovascular Diseases
Brest, France
View Trial Details